Search by Drug Name or NDC
NDC 63824-0023-36 Mucinex 1200 mg/1 Details
Mucinex 1200 mg/1
Mucinex is a ORAL TABLET, EXTENDED RELEASE in the HUMAN OTC DRUG category. It is labeled and distributed by RB Health (US) LLC. The primary component is GUAIFENESIN.
MedlinePlus Drug Summary
Guaifenesin is used to relieve chest congestion. Guaifenesin may help control symptoms but does not treat the cause of symptoms or speed recovery. Guaifenesin is in a class of medications called expectorants. It works by thinning the mucus in the air passages to make it easier to cough up the mucus and clear the airways.
Related Packages: 63824-0023-36Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Guaifenesin
Product Information
| NDC | 63824-0023 |
|---|---|
| Product ID | 63824-023_3749160e-0e3b-4c6c-8f36-d9fc7311f78f |
| Associated GPIs | 43200010007450 |
| GCN Sequence Number | 063103 |
| GCN Sequence Number Description | guaifenesin TAB ER 12H 1200 MG ORAL |
| HIC3 | B3J |
| HIC3 Description | EXPECTORANTS |
| GCN | 98863 |
| HICL Sequence Number | 000271 |
| HICL Sequence Number Description | GUAIFENESIN |
| Brand/Generic | Brand |
| Proprietary Name | Mucinex |
| Proprietary Name Suffix | Maximum Strength |
| Non-Proprietary Name | Guaifenesin |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | TABLET, EXTENDED RELEASE |
| Route | ORAL |
| Active Ingredient Strength | 1200 |
| Active Ingredient Units | mg/1 |
| Substance Name | GUAIFENESIN |
| Labeler Name | RB Health (US) LLC |
| Pharmaceutical Class | Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA021282 |
| Listing Certified Through | 2024-12-31 |
Package
Package Images
NDC 63824-0023-36 (63824002336)
| NDC Package Code | 63824-023-36 |
|---|---|
| Billing NDC | 63824002336 |
| Package | 2 BLISTER PACK in 1 CARTON (63824-023-36) / 14 TABLET, EXTENDED RELEASE in 1 BLISTER PACK |
| Marketing Start Date | 2012-06-26 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.81949 |
| Pricing Unit | EA |
| Effective Date | 2023-12-20 |
| NDC Description | MUCINEX ER 1,200 MG TABLET |
| Pharmacy Type Indicator | C/I |
| OTC | Y |
| Explanation Code | 2 |
| Classification for Rate Setting | B |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis
Standard Product Labeling (SPL)/Prescribing Information SPL 47f5323c-ee3a-400d-b133-31d9c286fafd Details
Uses
Warnings
Ask a doctor before use if you have
- persistent or chronic cough such as occurs with smoking, asthma, chronic bronchitis, or emphysema
- cough accompanied by too much phlegm (mucus)
Directions
Inactive ingredients
PRINCIPAL DISPLAY PANEL - 14 Tablet Blister Pack Carton
INGREDIENTS AND APPEARANCE
| MUCINEX
MAXIMUM STRENGTH
guaifenesin tablet, extended release |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Labeler - RB Health (US) LLC (081049410) |
Revised: 6/2022
Document Id: 3749160e-0e3b-4c6c-8f36-d9fc7311f78f
Set id: 47f5323c-ee3a-400d-b133-31d9c286fafd
Version: 13
Effective Time: 20220616